Viking Therapeutics, Inc. (LON:0VQA)
London · Delayed Price · Currency is GBP · Price in USD 38.67
+1.33 (3.55%)
At close: Aug 12, 2025
Paramount Global Market Cap
Viking Therapeutics has a market cap or net worth of 3.32 billion as of August 12, 2025. Its market cap has decreased by -41.68% in one year.
Market Cap
3.32B
Enterprise Value
2.72B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$38.67
Market Cap Chart
Since April 29, 2015, Viking Therapeutics's market cap has increased from 53.05M to 3.32B, an increase of 6,151.60%. That is a compound annual growth rate of 49.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 3.32B | -7.41% |
| Dec 31, 2024 | 3.58B | 145.09% |
| Dec 29, 2023 | 1.46B | 144.27% |
| Dec 30, 2022 | 598.29M | 125.11% |
| Dec 31, 2021 | 265.78M | -11.65% |
| Dec 31, 2020 | 300.83M | -31.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 169.37B |
| GSK plc | 55.99B |
| Haleon | 31.89B |
| Smith & Nephew | 11.72B |
| ConvaTec Group | 4.68B |
| Hikma Pharmaceuticals | 3.85B |
| Oxford Nanopore Technologies | 2.07B |
| HUTCHMED (China) | 1.93B |